Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Clinical Pharmacology in Drug Development|May 11, 2016
Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical StudiesPaul Martin, Michael Gillen, David Millson, et al.
The American Journal of Managed Care|November 17, 2017
The emerging role of gammaCore® in the management of cluster headache: expert panel recommendationsStephen D Silberstein, Anne H Calhoun, Christina Treppendahl, et al.
Cephalalgia : an International Journal of Headache|March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension studyStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Cephalalgia : an International Journal of Headache|August 9, 2018
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumabDawn C Buse, Richard B Lipton, Yngve Hallström, et al.
Neurology|June 10, 2016
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time pointsMarcelo E Bigal, David W Dodick, Abouch V Krymchantowski, et al.
NPJ Digital Medicine|May 13, 2026
Integrated analysis of two randomized controlled trials of a digital therapeutic for episodic migraine preventionShaheen E Lakhan, Mariya Petrova, Cassandra Snipes, et al.
Headache|March 4, 2025
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database-based observational cohort studyDavid W Dodick, Stewart J Tepper, Jessica Ailani, et al.
The Journal of Headache and Pain|May 16, 2023
The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regressionStewart J Tepper, Jessica Cirillo, Edward Kim, et al.
Headache|February 17, 2021
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) studyAriane K Kawata, Neel Shah, Jiat-Ling Poon, et al.
Headache|September 30, 2021
Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing dataDavid W Dodick, Stewart J Tepper, Jessica Ailani, et al.
Pageof 21